StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)

Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –

Medpace enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Medpace's enterprise value was $18.05B on Nov 11, 2026, against $16.40B a year earlier. Over the last 5 years it ranged from $4.35B to $18.05B, with a median of $9.31B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$18.05B+16.2%
2025Dec 31, 2025$15.54B+60.7%
2024Dec 31, 2024$9.67B+3.9%
2023Dec 29, 2023$9.31B+38.7%
2022Dec 30, 2022$6.71B-9.6%
2021Dec 31, 2021$7.42B+56.0%
2020Dec 31, 2020$4.76B+61.4%
2019Dec 31, 2019$2.95B+49.3%
2018Dec 31, 2018$1.98B+30.2%
2017Dec 29, 2017$1.52B-5.5%
2016Dec 30, 2016$1.61B–

More Medpace figures

See a number that looks wrong?